Singapore Cancer Diagnostics Startup Gets $77 Million in Funding

Singaporean biotechnology startup MiRXES Pte raised $77 million from investors led by CR-CP Life Science Fund to deliver early detection tests for cancer and other diseases.
( read original story …)


Search your Hotel